Effect of probiotics on five biochemical micrfloraassociated characteristics, in vitro and in vivo

References

• Fuller R: Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365–78.
   Google Scholar
• McFarland LV: A review of the evidence of health claims for biotherapeutic agents. Microb Ecol Health D is 2000; 12: 65–72.
   Google Scholar
• Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73 (2 Suppl): 430–6S.
   Google Scholar
• Isolauri E: Probiotics in human disease. Am J Clin Nutr 2001; 73: 1142–11465.
   Google Scholar
• Midtvedt T. Microbial functional activities. In: Hanson LA, Yolken RH, eds. Probiotics, other nutritional factors, and intestinal microflora. Nestlé Nutrition Work-shop, 1997, Vol. 42. Philadelphia: Lippincott-Raven, 1999: 79-96.
   Google Scholar
• Norin KE, Gustafsson BE, Midtvedt T: Strain differences in faecal tryptic activity of germ-free and conventional rats. Lab Anim 1986; 20: 67–9.
   PubMed Web of Science ®Google Scholar
• Welling GW, Helmus G, de Vries-Hospers HG, Tonk RHJ, van der Waaij D, Haralambie E, Linzenmeier G: Rationale for use of P-aspartylglycine as indicator of colonization resistance. Prog Clin Biol Res 1985; 181: 155–8.
   Google Scholar
• Corfield AP, Myerscough N, Longman R et al: Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 2000;47:58 9–94.
   Google Scholar
• Carlstedt-Duke B, Midtvedt T, Nord CE, Gustafsson BE: Isolation and characterization of a mucindegrading strain of Peptostreptococcus from rat intestinal tract. APMIS B 1986; 94: 293–300.
   Google Scholar
• Midtvedt T, Gustafsson BE: Microbial conversion of bilirubin to urobilins in vitro and in vivo. Acta Pathol Microbiol Scand B 1981; 89: 57–60.
   PubMedGoogle Scholar
• Gustafsson BE, Swenander-Lanke L. Bilirubin and urobilins in germfree, exgermfree and conventional rats. J Exp Med 1960; 112: 975–81.
   PubMed Web of Science ®Google Scholar
• ROd TO, Midtvedt T: Origin of intestinal beta-glucuronidase in germfree, monocontaminated and conventional rats. Acta Pathol Microbiol Scand B 1977; 85: 271–6.
   PubMedGoogle Scholar
• Cardona ME, de Vibe V, Midtvedt T, Norin KE: Probiotics in gnotobiotic mice. Conversion of choles-terol to coprostanol in vitro and in vivo and bile acid deconjugation in vitro. Microb Ecol Health D is 2000; 12:21 9-24.
   Google Scholar
• Welling GW, Groen G, Tuinte JH et al: Biochemical effects on germ-free mice of association with several strains of anaerobic bacteria. J Gen Microbiol 1980;117:5 7–63.
   Google Scholar
• Ramare F, Hautefort I, Verhe F et al: Inactivation of tryptic activity by a human-derived strain of Bac-teroides distasonis in the large intestines of gnotobiotic rats and mice. Appl Environ Microbiol 1996;62:143 4–6.
   Google Scholar
• Kroemer HK, Klotz U. Glucuronidation of drugs. A reevaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 1992; 23: 292–310.
   Google Scholar
• Aziz S, Kotal P, Leroy P et al: Bilirubin-IXalpha and -IXbeta pigments, coproporphyrins and bile acids in meconium and stools from full-term and preterm neonates during the first month of life. Acta Paediatr 2001;90:8 1–7.
   Google Scholar
• Hawksworth G, Drasar BS, Hill MJ: Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Micro-biol 1971;4:45 1–9.
   Google Scholar
• Gadelle D, Raibaud P, Sacquet E: Beta-glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl Environ Microbiol 1985;49:68 2–5.
   Google Scholar
• Tamura M, Hirayama K, Itoh K: Comparison of colonic bacterial enzymes in gnotobiotic mice monoassociated with different intestinal bacteria. Microb Ecol Health Dis 1996; 9: 287–94.
   Web of Science ®Google Scholar
• Hughes R, Rowland IR. Metabolic activities of the gut microflora in relation to cancer. Microb Ecol Health Dis 2000; 2 (Suppl): 179-85.
   Google Scholar